Abstract

CASE SERIES: MUCORMYCOSIS IN COVID-19 RECOVERED PATIENTS

Hirni J. Patel*, Meera R. Chauhan, Vidhya Shivadas, Elizabeth Philip and Mohammed Tousif Idrisi

.

Abstract

Background: Mucormycosis is a rare fungal infection mostly affecting in patients with recently recovered from Covid-19, diabetes Mellitus and immune-suppressed state. Methodology: The cases for current study were collected retrospectively which had confirmed diagnosis of mucormycosis in a single tertiary care hospital. The patient records were used for the clinical presentations. Case Presentation: In current study, five covid-19 recovered patients with mucormycosis were presented. The etiologic agents of mucormycosis swelling around eyes, pain in the eye, drooping of eyelids. Conclusion: Surgery, anti-fungal drugs and proper treatment of co-morbidities can improve outcome and survival if it’s diagnosed early and treated since mucormycosis is a rare and opportunistic fungal infection.

Keywords: Mucormycosis, Covid-19 recovered, fungal infection.